Novozymes A/S NVZMY Company Overview  Stock Message Board

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Novozymes A/S NVZMY Company Overview 

Stock Message Board http://investorshangout.com/search?q=NVZMY&am...mp;yt1=Go!

Novozymes A/S NVZMY Current Price and Quotes
36.325
Previous Close
36.855
Open
36.40

Daily Range
36.40 - 36.19
52wk Range
38.32 - 25.45

Volume
2,202
Dividend
0.2519

Average Vol (3m)
7,409
Yield
0.693462

Novozymes A/S NVZMY
Company Information
Krogshoejvej 36
Bagsvaerd 2880
Denmark

Website: http://www.novozymes.com
Phone: +45 4446 0000
Email: ckj@novozymes.com
Find us on:  

Novozymes A/S NVZMY
Novozymes is the biotech-based world leader in enzymes and microorganisms. With more than 100 types of enzymes and microorganisms and not less than 700 different products Novozymes has the largest product portfolio in the world.
In more than 40 different industries and 130 countries, our biological solutions improve industrial performance and quality while at the same time saving on water, energy, raw materials and waste. Novozymes is quoted on the Copenhagen Stock Exchange.

Novozymes A/S NVZMY
Financial Reportings and Disclosures
Reporting Status International Reporting: OMX Nordic Exchange Copenhagen
CIK 0001131345
Fiscal Year End 12/31
OTC Marketplace OTC Pink Current
Profile Data
SIC - Industry Classification 8880 - American Depositary Receipts
Incorporated In: Denmark
Year of Inc. Not Available
Employees 5824 a/o Dec 31, 2011
Company Officers/Contacts
Steen Riisgaard President, CEO
Thomas Steenbech Bonhoff Head of IR
Company Directors
Not Available
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Novozymes A/S NVZMY
NVZMY Security Details Other Company Securities
Share Structure
Market Value1 $1,970,677,746 a/o Aug 30, 2013
Shares Outstanding 54,251,280 a/o Jul 21, 2011
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders
Shareholders of Record Not Available
Corporate Actions
Ex. Date Record Date Pay Date
Dividend (0.25186) Mar 01, 2013 Mar 05, 2013 Mar 21, 2013
Dividend (0.25931) Mar 01, 2013 Mar 05, 2013 Mar 21, 2013
Dividend (0.22145) Mar 01, 2012 Mar 05, 2012 Mar 21, 2012
Non US Stock Exchange Listing
NZYMB - OMX Nordic Exchange Copenhagen - Qualified
Short Selling Data
Short Interest 7,228 (8.28%)
Aug 15, 2013
Significant Failures to Deliver  No
Transfer Agent(s)
BNY Mellon

Novozymes A/S NVZMY Recent News

Novozymes A/S NVZMY Financials
NVZMY

NVZMY Novozymes A/S Research DD Guide

NVZMY Novozymes A/S Stock Message Board http://investorshangout.com/search?q=NVZMY&am...mp;yt0=Go!
NVZMY Novozymes A/S Stock Quote http://www.otcmarkets.com/stock/NVZMY/quote
NVZMY Novozymes A/S Stock Chart http://www.otcmarkets.com/stock/NVZMY/chart
NVZMY Novozymes A/S Company Info http://www.otcmarkets.com/stock/NVZMY/company-info
NVZMY Novozymes A/S Recent News http://www.otcmarkets.com/stock/NVZMY/news
NVZMY Novozymes A/S Financials http://www.otcmarkets.com/stock/NVZMY/financials
NVZMY Novozymes A/S Filings and Disclosure http://www.otcmarkets.com/stock/NVZMY/filings
NVZMY Novozymes A/S Short Sales http://www.otcmarkets.com/stock/NVZMY/short-sales
NVZMY Novozymes A/S Insider Disclosure http://www.otcmarkets.com/stock/NVZMY/insider-transactions
NVZMY Novozymes A/S Research Reports http://www.otcmarkets.com/stock/NVZMY/research
NVZMY Novozymes A/S Summary http://finance.yahoo.com/q?s=NVZMY
NVZMY Novozymes A/S Historical Prices http://finance.yahoo.com/q/hp?s=NVZMY+Historical+Prices
NVZMY Novozymes A/S Interactive Chart http://finance.yahoo.com/echarts?s=NVZMY
NVZMY Novozymes A/S Basic Chart http://finance.yahoo.com/q/bc?s=NVZMY+Basic+Chart
NVZMY Novozymes A/S Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=NVZMY+Basic+Tech.+Analysis
NVZMY Novozymes A/S Headlines http://finance.yahoo.com/q/h?s=NVZMY+Headlines
NVZMY Novozymes A/S Press Releases http://finance.yahoo.com/q/p?s=NVZMY+Press+Releases
NVZMY Novozymes A/S Company Profile http://finance.yahoo.com/q/pr?s=NVZMY+Profile
NVZMY Novozymes A/S Key Statistics http://finance.yahoo.com/q/ks?s=NVZMY+Key+Statistics
NVZMY Novozymes A/S Industry http://finance.yahoo.com/q/in?s=NVZMY+Industry
NVZMY Novozymes A/S Major Holders http://finance.yahoo.com/q/mh?s=NVZMY+Major+Holders
NVZMY Novozymes A/S Insider Transactions http://finance.yahoo.com/q/it?s=NVZMY+Insider+Transactions
NVZMY Novozymes A/S Insider Roster http://finance.yahoo.com/q/ir?s=NVZMY+Insider+Roster
NVZMY Novozymes A/S Income Statement http://finance.yahoo.com/q/is?s=NVZMY
NVZMY Novozymes A/S Balance Sheet http://finance.yahoo.com/q/bs?s=NVZMY
NVZMY Novozymes A/S Cash Flow http://finance.yahoo.com/q/cf?s=NVZMY+Cash+Flow&annual
NVZMY Novozymes A/S Nasdaq http://www.nasdaq.com/symbol/NVZMY
NVZMY Novozymes A/S Market Watch http://www.marketwatch.com/investing/stock/NVZMY
NVZMY Novozymes A/S Bloomberg http://www.bloomberg.com/quote/NVZMY:US
NVZMY Novozymes A/S Morningstar http://quotes.morningstar.com/stock/s?t=NVZMY
NVZMY Novozymes A/S Bussinessweek http://investing.businessweek.com/research/st...cker=NVZMY
NVZMY Novozymes A/S Barchart http://www.barchart.com/quotes/stocks/NVZMY
NVZMY Novozymes A/S OTC Short Report http://otcshortreport.com/index.php?index=NVZMY
NVZMY Novozymes A/S Investopedia http://www.investopedia.com/markets/stocks/NVZMY/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 176

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 284

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 201

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 35

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 85

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 189

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading

Top 5 Most Recently Viewed Articles

Greenwave Technology Solutions CEO Discusses Scrap Metal Growth

Updated Category News Views 153

Greenwave Technology Solutions, Inc. CEO to be Featured on BNN Bloomberg Greenwave Technology Solutions, Inc. (NASDAQ: GWAV) is preparing for a significant media appearance that is set to shed light on the scrap metal industry and its promising future. CEO Danny Meeks is expected to be interviewed on BNN Bloomberg, providing insights into the company’s strategic...

Continue Reading
Exploring China's Transformation: A Look at Progress and Change

Updated Category News Views 207

China isn’t just a big country; it’s a beast that’s undergone an awe-inspiring metamorphosis over the decades. From ancient civilization whispers to a modern superpower roar, this nation has seen changes that make your head spin. As we close in on 75 years since the People's Republic was birthed, China's impressive transformation is undeniable. The China...

Continue Reading
Orion Group Holdings Launches $25 Million Common Stock Offering

Updated Category News Views 41

Orion Group Holdings Announces Public Offering Orion Group Holdings, Inc. (NYSE: ORN) has made a notable announcement about its new public offering of common stock. This move is part of the company's strategy to strengthen its financial base and enhance its operational capabilities in the construction industry. The offering includes 4,860,000 shares priced at $5.15 each,...

Continue Reading
Gaotu Techedu Inc. Set to Reveal Q4 and Fiscal Year Results

Updated Category News Views 109

Gaotu Techedu Inc. to Announce Quarterly Financial Results Gaotu Techedu Inc. (NYSE: GOTU), a prominent education technology company, recently disclosed plans to announce its financial results for the fourth quarter and the entire fiscal year 2024. This announcement will occur before the opening of U.S. markets on February 26. Investors and stakeholders are eager to learn...

Continue Reading
Chicago Atlantic Real Estate Finance Announces Q2 Results Date

Updated Category News Views 116

Chicago Atlantic Real Estate Finance Announces Q2 Earnings Release Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI), a prominent commercial mortgage real estate investment trust, has made significant announcements regarding its upcoming earnings report. Schedule for Earnings Release and Conference Call On a notable date of August 7, the Company plans to release...

Continue Reading